Dian Diagnostics Group Co.,Ltd.

Shenzhen Stock Exchange 300244.SZ

Dian Diagnostics Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 1.07 B

Dian Diagnostics Group Co.,Ltd. Shareholders' Equity is USD 1.07 B for the year ending December 31, 2023, a -1.26% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Dian Diagnostics Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 1.08 B, a 17.39% change year over year.
Dian Diagnostics Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 919.41 M, a 27.75% change year over year.
Dian Diagnostics Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 719.71 M, a 25.81% change year over year.
Dian Diagnostics Group Co.,Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 572.07 M, a 7.03% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shenzhen Stock Exchange: 300244.SZ

Dian Diagnostics Group Co.,Ltd.

CEO	Mr. Haibin Chen B.S. (EMBA)
IPO Date	July 19, 2011
Location	China
Headquarters	Building 2
Employees	10,843
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Drugstores & Retail Pharmacies Frozen Foods Hardware & Electronics Medical Instruments Pharmaceuticals Vaccines

Description

Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. The company operates 40 chain laboratories worldwide. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment and consumables; provision of medical equipment, drugs, clinical samples, biological products, virus and microorganisms, finished blood, live animals, compounds, and diagnostic reagents, as well as other cold chain transportation, warehousing services, cold chain product sales, and technical services. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.

Key trends

Past 5 years